My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 289

    1.

    The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.

    Mohan JS, Lip PL, Blann AD, Bareford D, Lip GY.

    Br J Ophthalmol. 2005 Jul;89(7):815-9.PMID: 15965157 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.

    Lip PL, Chatterjee S, Caine GJ, Hope-Ross M, Gibson J, Blann AD, Lip GY.

    Br J Ophthalmol. 2004 Dec;88(12):1543-6.PMID: 15548809 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.

    Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY.

    Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2115-9.PMID: 10892852 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.

    Caine GJ, Blann AD, Stonelake PS, Ryan P, Lip GY.

    Eur J Clin Invest. 2003 Oct;33(10):883-90.PMID: 14511360 [PubMed - indexed for MEDLINE]Related articles

    5.

    Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.

    Lim HS, Blann AD, Chong AY, Freestone B, Lip GY.

    Diabetes Care. 2004 Dec;27(12):2918-24.PMID: 15562207 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].

    Nadar SK, Blann A, Beevers DG, Lip GY.

    J Intern Med. 2005 Oct;258(4):336-43.PMID: 16164572 [PubMed - indexed for MEDLINE]Related articles

    7.

    Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.

    Lee KW, Lip GY, Blann AD.

    Circulation. 2004 Oct 19;110(16):2355-60. Epub 2004 Aug 9.PMID: 15302795 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.

    Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY.

    J Am Coll Cardiol. 2004 Feb 4;43(3):423-8.PMID: 15013125 [PubMed - indexed for MEDLINE]Related articles

    9.

    Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.

    Lim HS, Lip GY, Blann AD.

    Atherosclerosis. 2005 May;180(1):113-8. Epub 2004 Dec 21.PMID: 15823283 [PubMed - indexed for MEDLINE]Related articles

    10.

    Plasma markers of angiogenesis in pregnancy induced hypertension.

    Nadar SK, Karalis I, Al Yemeni E, Blann AD, Lip GY.

    Thromb Haemost. 2005 Nov;94(5):1071-6.PMID: 16363251 [PubMed - indexed for MEDLINE]Related articles

    11.

    Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.

    Caine GJ, Stonelake PS, Lip GY, Blann AD.

    Cancer Lett. 2007 Apr 8;248(1):131-6. Epub 2006 Aug 7.PMID: 16891056 [PubMed - indexed for MEDLINE]Related articles

    12.

    Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.

    Lip PL, Felmeden DC, Blann AD, Matheou N, Thakur S, Cunliffe IA, Lip GY.

    Br J Ophthalmol. 2002 Nov;86(11):1299-302.PMID: 12386093 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease.

    Chung NA, Lydakis C, Belgore F, Li-Saw-Hee FL, Blann AD, Lip GY.

    Heart. 2003 Dec;89(12):1411-5.PMID: 14617549 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.

    Caine GJ, Ryan P, Lip GY, Blann AD.

    Cancer Lett. 2007 Jun 28;251(2):296-301. Epub 2007 Jan 19.PMID: 17240049 [PubMed - indexed for MEDLINE]Related articles

    15.

    Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy.

    Wulff C, Wilson H, Dickson SE, Wiegand SJ, Fraser HM.

    Biol Reprod. 2002 Mar;66(3):802-12.PMID: 11870089 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease.

    Duits AJ, Rodriguez T, Schnog JJ; CURAMA Study Group.

    Br J Haematol. 2006 Jul;134(1):116-9.PMID: 16803577 [PubMed - indexed for MEDLINE]Related articles

    17.

    Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction.

    Clavel G, Bessis N, Lemeiter D, Fardellone P, Mejjad O, Ménard JF, Pouplin S, Boumier P, Vittecoq O, Le Loët X, Boissier MC.

    Clin Immunol. 2007 Aug;124(2):158-64. Epub 2007 Jun 8.PMID: 17560831 [PubMed - indexed for MEDLINE]Related articles

    18.

    Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors.

    Serefhanoglu S, Goker H, Buyukasik Y, Turgut M, Sayinalp N, Haznedaroglu IC, Aksu S, Akman U, Ozcebe OI.

    Ann Hematol. 2009 Jul;88(7):667-71. Epub 2008 Dec 11.PMID: 19082594 [PubMed - indexed for MEDLINE]Related articles

    19.

    Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?

    Lim HS, Tayebjee MH, Tan KT, Patel JV, Macfadyen RJ, Lip GY.

    Thromb Res. 2008;122(3):307-13. Epub 2007 Dec 3.PMID: 18054068 [PubMed - indexed for MEDLINE]Related articles

    20.

    Expression of angiopoietin-2 and vascular endothelial growth factor in mice cerebral cortex after permanent focal cerebral ischemia.

    Wang RG, Zhu XZ.

    Acta Pharmacol Sin. 2002 May;23(5):405-11.PMID: 11978190 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity